🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study evaluating the drug levels of ipilimumab alone and in combination w...
Status
Terminated
Location
Local Institution - 0020
Start Date
2020-06-25
Trial ID
NCT04311710
Treatments Being Tested
The main aim of this study is to learn if TAK-881 is safe and well tolerate...
Status
Active Not Recruiting
Location
University of California, Irvine Medical Sciences I
Start Date
2024-11-04
Trial ID
NCT06076642
Treatments Being Tested
The purpose of the study is to develop a subcutaneous treatment option for ...
Status
Completed
Location
Multiple Locations
Start Date
2008-12-18
Trial ID
NCT00814320
The study is being conducted to evaluate the safety, pharmacokinetics, and ...
Status
Not Yet Recruiting
Location
The Second Affiliated Hospital of Anhui Medical University
Start Date
2026-05-14
Trial ID
NCT07484893
Treatments Being Tested
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Active Not Recruiting
Location
Profound Research, LLC
Start Date
2024-12-17
Trial ID
NCT07667322
Treatments Being Tested
The main aims of this study are to check for side effects from TAK-881 in h...
Status
Completed
Location
Clinical Pharmacology of Miami
Start Date
2021-10-12
Trial ID
NCT05059977
Treatments Being Tested
This is an open-label, pilot study designed to explore whether daratumumab ...
Status
Completed
Location
The Litwin-Zucker Research Center
Start Date
2019-11-06
Trial ID
NCT04070378
Treatments Being Tested
Background: The experimental product in this study, N6LS, is a human monoc...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2018-06-21
Trial ID
NCT03538626
Treatments Being Tested
The main aim of this study is to evaluate the PK, safety, tolerability and ...
Status
Completed
Location
University of California Irvine Medical Center
Start Date
2023-10-24
Trial ID
NCT05755035
The objectives of this study are: * to establish the safety of subcutaneou...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00493220
Treatments Being Tested